Show simple item record

Resultados del tratamiento de la hepatitis crónica por virus C en un hospital público, en Chile.

dc.contributorNo hayes-ES
dc.creatorAravena, Edmundo
dc.creatorPinto, Andrea
dc.creatorRoblero, Juan Pablo
dc.creatorGonzález Z, Marcela
dc.creatorIturriaga, Hernán
dc.date2012-11-28
dc.date.accessioned2019-11-11T18:27:39Z
dc.date.available2019-11-11T18:27:39Z
dc.identifierhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/2011
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/111238
dc.descriptionRESULTS OF CHRONIC HEPATITIS C TREATMENT IN A PUBLIC HOSPITALBackground: Chronic hepatitis C is an important health problem in Chile. In 2005, the Ministry of Health started a pilot treatment program with peg interferon and ribavirin, to be developed in public hospitals all over the country. Aim: To report the results of hepatitis C treatment obtained at our institution. Patients and methods:  Between 2005 and 2009, 63 patients were referred for treatment. In all, the viral load and genotype were determined. Peg interferon alpha-2a or alpha-2b plus ribavirin were used for therapy for up to 48 weeks in genotypes (G) 1 or 4 or 24 weeks in genotypes 2 or 3. If at the end of treatment, viral load measured by polymerase chain reaction (PCR) was negative, it was repeated 6 months later. A negative viral load at that time was considered a sustained viral response (SVR). Results: Among the 51 patients who started treatment, 42 (80.4%) were G1, 1 was G2 , 1 was G4 and 7 were G3. A SVR was reached in 51,1% of G 1 and 4 and in 87.5% in G 3 and 2. In a univariate analysis, the variables significantly associated with a positive viral response were the degree of fibrosis and body mass index. Conclusions: These results are similar to those obtained in the best international series, demonstrating that Hispanic ethnicity does not influence the response to treatment. Our good results could be explained by the excellent compliance of the patients to the treatment. A higher degree of fibrosis and a higher BMI were associated with a poor response.          es-ES
dc.languagees
dc.publisherRevista Médica de Chilees-ES
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/2011/5308
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/2011/5309
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/2011/5310
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/2011/5311
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/2011/5312
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/2011/5313
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/2011/5880
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/2011/5881
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/2011/5882
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/2011/5883
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/2011/5884
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/2011/6822
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/2011/6823
dc.sourceRevista Médica de Chile; Vol. 140, núm. 12 (2012): DICIEMBRE 2012es-ES
dc.source0034-9887
dc.subjectHepatitis C, chronic; Peginterferon alfa-2a; Peginterferon alfa-2b; Ribavirines-ES
dc.titleResultados del tratamiento de la hepatitis crónica por virus C en un hospital público, en Chile.es-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typees-ES


This item appears in the following Collection(s)

Show simple item record